PS179. A depressive patient who achieved remission by escitalopram: cerebral blood flow variation during pleasant/unpleasant image tasks.

نویسندگان

  • Yoshihisa Shoji
  • Masayuki Inoue
  • Youhei Ishii
  • Yusuke Kato
  • Kiichiro Morita
  • Naohisa Uchimira
  • Yuki Yamashita
  • Hiroko Yanagimoto
چکیده

s | 65 PS179 A depressive patient who achieved remission by escitalopram: cerebral blood flow variation during pleasant/unpleasant image tasks. Yoshihisa Shoji, Masayuki Inoue, Youhei Ishii, Yusuke Kato, Kiichiro Morita, Naohisa Uchimira, Yuki Yamashita, Hiroko Yanagimoto Cognitive and Molecular Research Institute of Brain Diseases, Kurume

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

PS181. A study of hippocampal volumes in first-episode, drug-naïve major depression disorder.

s | 65 PS179 A depressive patient who achieved remission by escitalopram: cerebral blood flow variation during pleasant/unpleasant image tasks. Yoshihisa Shoji, Masayuki Inoue, Youhei Ishii, Yusuke Kato, Kiichiro Morita, Naohisa Uchimira, Yuki Yamashita, Hiroko Yanagimoto Cognitive and Molecular Research Institute of Brain Diseases, Kurume

متن کامل

PS180. Relationship between frontal lobe function and antidepressant treatment in bipolar disorder and major depressive disorder: a near-infrared spectroscopy study

s | 65 PS179 A depressive patient who achieved remission by escitalopram: cerebral blood flow variation during pleasant/unpleasant image tasks. Yoshihisa Shoji, Masayuki Inoue, Youhei Ishii, Yusuke Kato, Kiichiro Morita, Naohisa Uchimira, Yuki Yamashita, Hiroko Yanagimoto Cognitive and Molecular Research Institute of Brain Diseases, Kurume

متن کامل

Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study

BACKGROUND Escitalopram is licensed for use at doses up to 20 mg but is used clinically at higher doses. There is limited published data at higher doses and none in the treatment of Major Depressive Disorder (MDD). METHODS This open-label, pilot study was designed to investigate the efficacy, safety and tolerability of escitalopram in doses up to 50 mg in MDD. It was conducted in 60 primary c...

متن کامل

Emotions in unmedicated patients with schizophrenia during evaluation with positron emission tomography.

OBJECTIVE Schizophrenia is currently conceptualized as a disease of functional neural connectivity, leading to symptoms that affect aspects of mental activity, including perception, attention, memory, and emotion. The neural substrates of its emotional components have not been extensively studied with functional neuroimaging. Previous neuroimaging studies have examined medicated patients with s...

متن کامل

Subchronic SSRI administration reduces insula response during affective anticipation in healthy volunteers.

The anterior cingulate cortex (ACC) and insula are important neural substrates for the integration of cognitive, emotional, and physiological information, as well as the coordination of responses to anticipated stimuli. Increased neural activation within these structures has been observed in individuals with anxiety and depressive disorders. Selective serotonin reuptake inhibitors (SSRIs) are a...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 19  شماره 

صفحات  -

تاریخ انتشار 2016